Aethlon Medical Inc (NAS:AEMD)
$ 0.4 -0.4501 (-52.95%) Market Cap: 1.05 Mil Enterprise Value: -4.73 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 51/100

Aethlon Medical Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript

Feb 02, 2023 / 03:00PM GMT
Release Date Price: $6.6 (-5.70%)
Steven LaRosa
Aethlon Medical, Inc. - Chief Medical Officer & Chief Scientific Officer

Hello. This is Steven LaRosa; I'm the Chief Medical Officer and Chief Scientific Officer at Aethlon Medical. I will be presenting on behalf of Aethlon Medical for the Sequire Biotechnology Conference. I want to acknowledge that this presentation contains forward-looking statements. Please read the disclaimer below with all the caveats around forward-looking statements at your convenience.

First, I'd like to describe Aethlon Medical. We're headquartered in San Diego, California. We're listed on NASDAQ under the ticker AEMD. We're focused on combating cancer and infectious diseases with immunotherapeutic technologies. Aethlon's Hemopurifier, our investigational device, has demonstrated the capture of disease-promoting exosomes and circulating viruses in clinical trials and emergency use.

Aethlon has a senior management team with extensive experience in both medical devices and therapeutics. Listed on the right-hand side of the slide are the number of companies and the products that our management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot